Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

The Global Reproductive Genetics Market is estimated to be valued at USD 7.31 Bn in 2025 and is expected to reach USD 16.67 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from ...

The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...

A significant number of Tuberculosis (TB) cases continue to go undetected due to the limited sensitivity of smear microscopy, the most commonly used diagnostic test for TB in India.

In winter, various respiratory infectious diseases such as influenza (flu), pneumonia, and COVID-19 are prevalent at the same ...

Approaches incorporating rapid or digital PCR, CRISPR, syndromic testing, and multimodal systems reached new milestones this year.

Roche’s cobas BV/CV assay gains CE Mark, enabling accurate, rapid diagnosis of bacterial vaginosis and candida vaginitis.

Among adults with evidence of systemic mast cell activation, bone marrow samples allowed for detection of 13 additional ...

The world of medical testing is always changing, and point-of-care molecular diagnostics are a big part of that. These tests let us find out what’s going on with a patient’s health right there, ...

Earlier this year the Therapeutic Goods Administration (TGA) halted the sale of 21 sunscreen products in Australia following ...

A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks. The service ...

Global HPV Testing and PAP Test Market OverviewThe global HPV testing and PAP tests market is projected to expand steadily, registering a compound annual growth rate of approximately 12–15% through ...